- 4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
- 4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
- 4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
Key statistics
On Monday, 4Basebio PLC (4BB:LSE) closed at 1,220.00, 2.69% below its 52-week high of 1,188.00, set on May 10, 2024.
52-week range
Open | 1,160.00 |
---|---|
High | 1,170.00 |
Low | 1,090.00 |
Bid | 1,150.00 |
Offer | 1,250.00 |
Previous close | 1,160.00 |
Average volume | 1.65k |
---|---|
Shares outstanding | 12.81m |
Free float | 3.89m |
P/E (TTM) | -- |
Market cap | 148.54m GBP |
EPS (TTM) | -0.5094 GBP |
Data delayed at least 20 minutes, as of May 13 2024 16:35 BST.
More ▼